Argus Reiterates Corteva Buy with $91 Target; Cramer Sidelines on CTVA
Sep 29, 2026, 12:55 PM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
A formal Buy rating with a target provides a clear upside path from current levels (~$77.74) toward ~$91, subject to market momentum and fundamentals. Historical reactions to price-target upgrades often materialize within weeks, though execution risk remains if the broader market weakens.
AI summary
What happened, with direct paths to the underlying reporting
Argus Research reaffirmed Corteva (CTVA) as a Buy with a $91 target on Sept 18, presenting a near-term upside catalyst that could lift shares toward the target. Jim Cramer hasn’t weighed in on Corteva, leaving upside potential reliant on external analyst sentiment and future company news. The stock traded around $77.74, down 1% Monday amid broader market chatter about other high-growth and high-yield names.
Argus reiterates Corteva Buy with a $91 target on Sept 18. Cramer has not reviewed CTVA.
CTVA traded about $77.74, down 1% Monday, setting up potential upside if catalysts emerge.
Forgent Power Solutions posted a Q4 beat: EPS 0.25, sales $461.67M, up 94% YoY; 2027 guidance above estimates.
Symbotic and Polaris tones show mixed sentiment, illustrating broader market caution around high-growth or high-yield names.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Corteva has announced its plan to separate into two publicly traded entities by Q4 2023. This corporate restructuring could enhance operational efficiency and provide distinct foc…
Corteva's performance in Phase 9 is under analysis due to its Cakra structure, suggesting potential stock trajectory changes. Investors may want to track these indicators for bett…
Corteva plans to separate seed and pesticide businesses into two public companies. This move aims to enhance strategic focus and improve shareholder returns.
Corteva is considering a split into two companies to mitigate lawsuit risks. Market reports indicate an announcement could come soon from Corteva. Corteva and Bayer dominate the U…